GLP-1 Receptor Agonists Are Associated with Reduced Ascending Aorta Dilatation in Patients with Type 2 Diabetes: A Prospective Study
International Journal of Molecular Sciences · 14.10.2025 · 26 (20) · 9977
DOI: 10.3390/ijms26209977 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 14.10.2025. Verfasst von Celestino Sardu und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", 80126 Naples, Italy. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Glucagon-Like Peptide-1 Receptor Agonists, Aorta, Hypoglycemic Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
The aim was to assess the impact of glucagon-like peptide-1 receptor agonists (GLP-1 RA) treatment on the progression of ascending aorta dilatation in patients with type 2 diabetes mellitus (T2DM). A total of 127 T2DM patients with subclinical ascending aortic dilatation (35–45 mm) were prospectively enrolled. Fifty-seven initiated GLP-1 RA therapy (liraglutide, semaglutide, or dulaglutide), while 70 continued on standard care. Ascending aortic diameter was measured by computed tomography angiography (CTA) at baseline and 24 months, alongside circulating markers of vascular remodeling: matrix metalloproteinase-9 (MMP-9), tissue inhibitor of metalloproteinases-1 (TIMP-1), C-reactive protein (CRP), and osteoprotegerin (OPG). Progression of aortic dilatation was significantly lower in the GLP-1 RA group compared with controls (+0.36 ± 0.20 mm vs. +1.05 ± 0.28 mm; p < 0.001). Therapy correlated with decreased MMP-9 and CRP (p < 0.01) and increased TIMP-1 and OPG (p < 0.05). The use of GLP-1 RA was an independent predictor of low progression, even in multivariate models after adjusting for demographic, metabolic, and biomarker data. GLP-1 RA therapy was associated with reduced progression of ascending aortic dilatation in T2DM, supporting a potential vasoprotective role beyond glucose lowering.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", 80126 Naples, Italy.
- Pollution and Cardiovascular Diseases Research Centre, University of Campania "Luigi Vanvitelli", 81100 Caserta, Italy.
- Department of Precision Medicine, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy.
- Department of Cardiology, AORN Antonio Cardarelli, 80131 Naples, Italy.
- Department of Clinical Research, Nefrocenter Research Network, Via XXV Luglio, 160, 84013 Cava de Tirreni, Italy.
ORCID-Profile: Celestino Sardu, Ferdinando Carlo Sasso, Ciro Romano, Caterina Carusone, Alessandro Bellis, Nunzia D'Onofrio, Maria Luisa Balestrieri, Raffaele Marfella
Zitieren
APA
Sardu, C., Marfella, L. V., Fumagalli, C., Rinaldi, L., Sasso, F. C., Cozzolino, D., Nappo, F., Sellitto, A., Romano, C., Carusone, C., Russo, P., Marfella, L., Tarantino, N. M., Carpinella, G., Furbatto, F., Gentile, S., Guarino, G., Satta, E., Bellis, A., …, & Marfella, R. (2025). GLP-1 Receptor Agonists Are Associated with Reduced Ascending Aorta Dilatation in Patients with Type 2 Diabetes: A Prospective Study. International Journal of Molecular Sciences, 26(20), 9977. https://doi.org/10.3390/ijms26209977
Vancouver
Sardu C, Marfella LV, Fumagalli C, Rinaldi L, Sasso FC, Cozzolino D, et al. GLP-1 Receptor Agonists Are Associated with Reduced Ascending Aorta Dilatation in Patients with Type 2 Diabetes: A Prospective Study. International Journal of Molecular Sciences. 2025;26(20):9977. doi:10.3390/ijms26209977
BibTeX
@article{Sardu2025,
author = {Sardu, Celestino and Marfella, Ludovica Vittoria and Fumagalli, Carlo and Rinaldi, Luca and Sasso, Ferdinando Carlo and Cozzolino, Domenico and Nappo, Francesco and Sellitto, Ausilia and Romano, Ciro and Carusone, Caterina and Russo, Pasquale and Marfella, Lorenza and Tarantino, Nicola Maria and Carpinella, Gerardo and Furbatto, Fulvio and Gentile, Sandro and Guarino, Giuseppina and Satta, Ersilia and Bellis, Alessandro and Marinelli, Luca and Donisi, Isabella and D'Onofrio, Nunzia and Mauro, Ciro and Cappabianca, Salvatore and Balestrieri, Maria Luisa and Marfella, Raffaele},
title = {GLP-1 Receptor Agonists Are Associated with Reduced Ascending Aorta Dilatation in Patients with Type 2 Diabetes: A Prospective Study},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {20},
pages = {9977},
doi = {10.3390/ijms26209977}
}
EUVIMED